Literature DB >> 30488368

Risk factors for carbapenem-resistant Enterobacteriaceae infections: a French case-control-control study.

Marie-Hélène Nicolas-Chanoine1,2, Marie Vigan3,4, Cédric Laouénan5,3,4, Jérôme Robert6,7.   

Abstract

This study aimed to assess characteristics associated with infections due to carbapenem-resistant Enterobacteriaceae (CRE), producing (CPE) or not producing (non-CPE) carbapenemase, among hospitalised patients in 2014-2016 in France. Case-patients with CRE were compared to two control populations. In multivariate analysis comparing 160 CRE cases to 160 controls C1 (patients with a clinical sample positive for carbapenem-susceptible Enterobacteriaceae), five characteristics were linked to CRE: male gender (OR = 1.9; 95% CI = 1.3-3.4), travel in Asia (OR = 10.0; 95% CI = 1.1-91.2) and hospitalisation in (OR = 2.4; 95% CI = 1.3-4.4) or out of (OR = 4.4; 95% CI = 0.8-24.1) France in the preceding 12 months, infection in the preceding 3 months (OR = 3.0; 95% CI = 1.5-5.9), and antibiotic receipt between admission and inclusion (OR = 1.9; 95% CI = 1.0-3.3). In multivariate analysis comparing 148 CRE cases to 148 controls C2 [patients with culture-negative sample(s)], four characteristics were identified: prior infection (OR = 3.3; 95% CI = 1.6-6.8), urine drainage (OR = 3.0; 95% CI = 1.5-6.1) and mechanical ventilation (OR = 3.7; 95% CI = 1.1-13.0) during the current hospitalisation, and antibiotic receipt between admission and inclusion (OR = 6.6; 95% CI = 2.8-15.5). Univariate analyses comparing separately CPE cases to controls (39 CPE vs C1 and 36 CPE vs C2) and non-CPE cases to controls (121 non-CPE vs C1 and 112 non-CPE vs C2), concomitantly with comparison of CPE to non-CPE cases showed that only CPE cases were at risk of previous travel and hospitalisation abroad. This study shows that, among CRE, risk factors are different for CPE and non-CPE infection, and suggests that question patients about their medical history and lifestyle should help for early identification of patients at risk of CPE among patients with CRE.

Entities:  

Keywords:  Carbapenem-resistant Enterobacteriaceae (CRE); Carbapenemase-producing Enterobacteriaceae (CPE); Case-control-control study; Multicentre study; Risk factors

Mesh:

Substances:

Year:  2018        PMID: 30488368     DOI: 10.1007/s10096-018-3438-9

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  13 in total

1.  Frequency of and risk factors for carbapenem-resistant Enterobacteriaceae.

Authors:  Katie E Barber; Jamie L Wagner; Rachel C Larry; Kayla R Stover
Journal:  J Med Microbiol       Date:  2021-02       Impact factor: 2.472

2.  A multidrug-resistant microorganism infection risk prediction model: development and validation in an emergency medicine population.

Authors:  Juan González Del Castillo; Agustín Julián-Jiménez; Julio Javier Gamazo-Del Rio; Eric Jorge García-Lamberechts; Ferrán Llopis-Roca; Josep María Guardiola Tey; Mikel Martínez-Ortiz de Zarate; Carmen Navarro Bustos; Pascual Piñera Salmerón; Jesús Álvarez-Manzanares; María Del Mar Ortega Romero; Martin Ruiz Grinspan; Susana García Gutiérrez; Francisco Javier Martín-Sánchez; Francisco Javier Candel González
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-11-13       Impact factor: 3.267

3.  Intestinal Colonization Due to Carbapenem-Resistant Enterobacteriaceae Among Hematological Malignancy Patients in India: Prevalence and Molecular Charecterisation.

Authors:  Amarjeet Kumar; Sarita Mohapatra; Raunak Bir; Sonu Tyagi; Sameer Bakhshi; Manoranjan Mahapatra; Hitender Gautam; Seema Sood; Bimal Kumar Das; Arti Kapil
Journal:  Indian J Hematol Blood Transfus       Date:  2021-02-24       Impact factor: 0.900

4.  Association between Antimicrobial Consumption and the Prevalence of Nosocomial Carbapenem-Resistant Escherichia coli and Klebsiella pneumoniae in a Tertiary Hospital in Northern Taiwan.

Authors:  Mei-Chun Lee; Hsun Chang; Fang-Ju Sun; Alice Ying-Jung Wu; Chien-Hung Lu; Chun-Ming Lee
Journal:  Am J Trop Med Hyg       Date:  2022-06-13       Impact factor: 3.707

Review 5.  Rise in the prevalence of resistance to extended-spectrum cephalosporins in the USA, nursing homes and antibiotic prescribing in outpatient and inpatient settings.

Authors:  Edward Goldstein
Journal:  J Antimicrob Chemother       Date:  2021-10-11       Impact factor: 5.758

6.  Risk factors for Klebsiella pneumoniae carbapenemase (KPC) gene acquisition and clinical outcomes across multiple bacterial species.

Authors:  A J Mathers; K Vegesana; I German-Mesner; J Ainsworth; A Pannone; D W Crook; C D Sifri; A Sheppard; N Stoesser; T Peto; A S Walker; D W Eyre
Journal:  J Hosp Infect       Date:  2020-01-10       Impact factor: 3.926

7.  A matched case-control study to assess the carbapenem-resistant Enterobacteriaceae infections among hospitalized children at King Fahad Medical City, Riyadh, Saudi Arabia.

Authors:  Omar A Alzomor; Tariq S Alfawaz; Amani Abu-Shaheen; Mohammed A Alshehri; Dayel Al Shahrani
Journal:  Saudi Med J       Date:  2019-11       Impact factor: 1.484

8.  Geographical differences of carbapenem non-susceptible Enterobacterales and Acinetobacter spp. in Germany from 2017 to 2019.

Authors:  Anja von Laer; Tim Eckmanns; Benedikt Zacher; Niels Pfennigwerth; Sören G Gatermann; Felix Reichert; Michaela Diercke; Gyde Steffen; Doris Altmann; Annicka Reuss
Journal:  Antimicrob Resist Infect Control       Date:  2022-02-04       Impact factor: 4.887

9.  Global Distribution Patterns of Carbapenemase-Encoding Bacteria in a New Light: Clues on a Role for Ethnicity.

Authors:  Claudio Neidhöfer; Christian Buechler; Guido Neidhöfer; Gabriele Bierbaum; Irene Hannet; Achim Hoerauf; Marijo Parčina
Journal:  Front Cell Infect Microbiol       Date:  2021-06-29       Impact factor: 5.293

10.  Impact of different carbapenemase-producing Enterobacterales screening strategies in a hospital setting.

Authors:  C E Corless; A M Howard; T J Neal
Journal:  Infect Prev Pract       Date:  2020-05-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.